文献速递治疗药物监测与药物基因组学特殊人群用药

PharmVar GeneFocus:NAT2基因变异及其命名更新

PharmVar GeneFocus: NAT2-Genetic Variation and Updated Nomenclature.
PubMed 文献 · Clin Pharmacol Ther · 2025-12-23

PharmVar对高多态性NAT2基因提供命名规范,该基因代谢异烟肼、肼屈嗪、阿米法普利定、普鲁卡因胺和氨苯砜等药物。本文概述NAT2变异及其2024年3月转入PharmVar后星号等位基因命名的重大变化,并讨论等位变异表征和全球人群等位基因频率确定的挑战。新的NAT2 PharmVar命名已被ClinPGx和CPIC采用。

要点

  • NAT2代谢异烟肼、肼屈嗪、阿米法普利定、普鲁卡因胺和氨苯砜等临床药物。
  • 2024年3月NAT2命名转入PharmVar并发生重要变化。
  • 新命名已被ClinPGx和CPIC采用。

核心结论

  • PharmVar提供了NAT2基因的命名规范,其2024年3月转入PharmVar后星号等位基因命名发生重要变化。
  • 新的NAT2 PharmVar命名已被ClinPGx和CPIC采用。

研究设计与样本

  • 本文为PharmVar基因聚焦综述,概述NAT2变异及其命名变化。

主要发现

  • NAT2代谢异烟肼、肼屈嗪、阿米法普利定、普鲁卡因胺和氨苯砜等临床药物。
  • NAT2变异命名对药物遗传学检测、基因型解读及表型转化至关重要。
  • 等位变异表征和全球人群等位基因频率确定存在挑战。

临床怎么用

  • 临床药物遗传学检测和基因型解读应采用PharmVar更新的NAT2命名。
  • ClinPGx和CPIC已采用新的NAT2 PharmVar命名。

局限性

  • 等位变异表征和全球人群等位基因频率确定存在挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human N-acetyltransferase 2 (NAT2) gene. NAT2 metabolizes several clinically used drugs including isoniazid, hydralazine, amifampridine, procainamide, and sulfonamides such as dapsone, and also some highly carcinogenic arylamines. Systematic nomenclature describing NAT2 variation is essential for pharmacogenetic testing, genotype interpretation, and translation to phenotype in research and clinical settings. This GeneFocus provides an overview of NAT2 variation and describes important changes to its star allele-based nomenclature that were made as it was transitioned to PharmVar in March 2024. We also highlight and discuss challenges regarding the characterization of allelic variation and determination of allele frequencies across world populations. The "new" NAT2 PharmVar nomenclature is utilized by ClinPGx (formerly PharmGKB) and the Clinical Pharmacogenetics Implementation Consortium (CPIC).

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Papanikolaou G, Poloni ES, Agúndez JAG, et al. PharmVar GeneFocus: NAT2-Genetic Variation and Updated Nomenclature. Clin Pharmacol Ther. 2025. PMID: 41432551. doi:10.1002/cpt.70168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。